Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Islet transplantation: present and future perspectives.

N S Kenyon1, A Ranuncoli, M Masetti

  • 1Diabetes Research Institute, University of Miami School of Medicine, FL 33136, USA.

Diabetes/Metabolism Reviews
|March 30, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editorial - ERMPS Healthspan: to improve lifespan in physical and mental health.

European review for medical and pharmacological sciences·2023
Same author

Modulation of inflammation and immunity by omega-3 fatty acids: a possible role for prevention and to halt disease progression in autoimmune, viral, and age-related disorders.

European review for medical and pharmacological sciences·2023
Same author

The potential therapeutic role of vitamin D in inflammatory bowel disease.

European review for medical and pharmacological sciences·2023
Same author

The importance of vitamin D and omega-3 PUFA supplementation: a nonpharmacologic immunomodulation strategy to halt autoimmunity.

European review for medical and pharmacological sciences·2022
Same author

MESENCHYMAL STEM CELLS.

CellR4-- repair, replacement, regeneration, & reprogramming·2021
Same author

Editorial - Announcing changes in the Editorial Board.

European review for medical and pharmacological sciences·2021
Same journal

The preliminary report from the nation-wide prevention study for type 1 diabetes initially diagnosed as type 2 in Japan.

Diabetes/metabolism reviews·1999
Same journal

Cryptic epitope and autoimmunity.

Diabetes/metabolism reviews·1999
Same journal

Neogenesis of islet cells.

Diabetes/metabolism reviews·1999
Same journal

Lazarus rises: islet regeneration in the 21st century.

Diabetes/metabolism reviews·1999
Same journal

Insulin expression in the thymus, tolerance, and type 1 diabetes.

Diabetes/metabolism reviews·1999
Same journal

Actual perspectives in biohybrid artificial pancreas for the therapy of type 1, insulin-dependent diabetes mellitus.

Diabetes/metabolism reviews·1999
See all related articles

Islet cell transplantation shows promise for managing Type 1 diabetes by normalizing blood glucose. However, challenges like engraftment, rejection, and immunosuppression side effects must be overcome for wider application.

Area of Science:

  • Endocrinology
  • Transplantation Immunology

Background:

  • Islet cell transplantation offers potential for normalizing blood glucose and preventing complications in Type 1 diabetes.
  • Recent advancements have shown success in metabolic control, but insulin independence remains elusive for most patients.

Purpose of the Study:

  • To review the current state of islet cell transplantation for Type 1 diabetes.
  • To identify key challenges hindering broader clinical application and discuss future research directions.

Main Methods:

  • Review of recent scientific literature on islet cell transplantation.
  • Analysis of outcomes, complications, and unresolved issues in Type 1 diabetes treatment.

Main Results:

  • Successful normalization of metabolic control achieved in some patients without hypoglycemia.

Related Experiment Videos

  • Limited success in achieving long-term insulin independence.
  • Significant challenges persist regarding islet engraftment, immune rejection, and recurrent autoimmunity.

    • Conclusions:

    • Islet cell transplantation holds significant therapeutic potential for Type 1 diabetes.
    • Overcoming challenges in engraftment, immunosuppression, and immune tolerance is crucial for expanding patient eligibility.
    • Development of targeted immunointervention strategies is needed to make this procedure suitable for all patients.